Avantax Advisory Services, Inc. Neurocrine Biosciences Inc Transaction History
Avantax Advisory Services, Inc.
- $16 Billion
- Q1 2025
A detailed history of Avantax Advisory Services, Inc. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Avantax Advisory Services, Inc. holds 2,112 shares of NBIX stock, worth $263,514. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,112
Previous 2,895
27.05%
Holding current value
$263,514
Previous $395,000
41.01%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding NBIX
# of Institutions
649Shares Held
97.1MCall Options Held
749KPut Options Held
553K-
Black Rock Inc. New York, NY14.2MShares$1.77 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.94MShares$1.24 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.53MShares$691 Million0.37% of portfolio
-
State Street Corp Boston, MA4.86MShares$607 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY2.67MShares$333 Million0.02% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $11.9B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...